Chrysoeriol might serve as a beneficial supplement or adjuvant for the prevention or treatment of estrogen receptor-positive breast cancer with the potential to inhibit local estrogen production in the tumor microenvironment in breast cancer. This evidence concerns the gene ESR1 and breast cancer.